|
|
|
|
|

|
Pulmonary Disease
Management of Chronic Obstructive Pulmonary Disease: Review Questions
Yuji Oba, MD, FCCP

Dr.Oba is an assistant professor on medicine, University of Missouri-Kansas City, Kansas City, MO.
Choose the single best answer for each question.
|
Questions 1 and 2 refer to the following case study.
A 65-year-old man presents to his physicians office with a 6-month history of wheezing, dyspnea on exertion, and daily sputum production. He is a 50 pack-year smoker but is otherwise healthy. Examination shows markedly decreased breath sounds with mild wheezing at the end of expiration. When spirometry is performed, his forced expiratory volume in 1 second (FEV1) is 1.5 L (60% of predicted). His forced vital capacity (FVC) is 2.3 L. The FEV1/FVC ratio is 0.65.
1. Which of the following interventions will be most effective for improving this patients long-term survival?
- Inhaled corticosteroids
- Long-term oral corticosteroids
- Inhaled ipratropium
- Smoking cessation
Click here to compare your answer.
2. Which of the following is the best management option for this patient?
- Inhaled ipratropium as needed
- Inhaled albuterol as needed
- A short-acting bronchodilator as needed and regular treatment with a long-acting bronchodilator
- An inhaled corticosteroid
Click here to compare your answer.
|
 |
3. Which of the following statements regarding corticosteroid therapy in patients with an exacerbation of chronic obstructive pulmonary disease (COPD) is true?
- Systemic corticosteroids should be given for more than 2 weeks to prevent treatment failure
- Systemic corticosteroids improve survival
- Intravenous therapy is better than oral therapy
- Systemic corticosteroids reduce hospital stays by 1 to 2 days
Click here to compare your answer.
4. A 57-year-old woman is discharged from the hospital after an exacerbation of COPD. She has finished a course of antibiotics, and her current regimen includes salmeterol 2 puffs twice per day, albuterol 2 puffs every 6 hours as needed, and a tapering dose of prednisone. She has had COPD exacerbations 2 to 3 times per year for the last 2 years. She quit smoking 3 years ago, received a dose of pneumococcal vaccine 3 years ago, and had a flu shot this year. Her most recent spirometry showed FEV1 of 1.1 L (45% of predicted) with no significant bronchodilator response. Her oxygen saturation on room air is 90%, and she has no signs of cor pulmonale. Which of the following is the best management option for this patient?
- Arrange home oxygen therapy
- Perform a PPD skin test
- Maintain the patient on chronic oral prednisone
- Add an inhaled corticosteroid
- Start therapy with oral theophylline
Click here to compare your answer.
|
|
Hospital Physician
JCOM
Seminars in Medical Practice
Hospital Physician Board Review Manuals
About TWC
Subscribe
Contact TWC
Home
Search
Site Map
Copyright © 2008, Turner White Communications
Updated 1/04/08 kkj
|